Overview

Double-Blind Comparison of the Efficacy of Continued Zidovudine Versus 2',3'-Dideoxyinosine (ddI) (BMY-40900) for the Treatment of Patients With AIDS or AIDS-Related Complex and Increasing Symptomatology Despite Treatment With Zidovudine

Status:
Completed

Trial end date:
1992-04-01

Target enrollment:

Participant gender:

Summary

To compare the efficacy and safety of orally administered didanosine (ddI) with orally administered zidovudine (AZT) in the treatment of patients who exhibit increasing clinical deterioration despite treatment with AZT.

Phase:

N/A

Details

Lead Sponsor:

Bristol-Myers Squibb

Treatments:

Didanosine
Zidovudine